All you need to know about managing hepatitis C virus infection in Australia

What’s new in the June 2020 Consensus Statement?

  • Prescribing by nurse practitioners
  • Removal of the PBS requirement to document HCV genotype before prescribing pan-genotypic treatment regimens for hepatitis C
  • PBS listing of sofosbuvir plus velpatasvir plus voxilaprevir
  • Removal of the PBS requirement that patients be aged 18 years or older before prescribing treatment for hepatitis C
  • TGA approves the first point-of-care assay for hepatitis C
Read More

BROWSE TOPICS

Epidemiology and Models of Care

Screening and diagnosis

Pre-treatment assessment

Treatment for chronic hepatitis C

On-treatment monitoring

Post-treatment follow-up

Treating special populations

Decompensated liver disease After liver transplantation HIV coinfection HBV coinfection Renal impairment Acute HCV infection

DAA therapy & risk of HCC in people with cirrhosis

CONTRIBUTORS